BioCardia, Inc.

BCDA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
360
SEC Filings

Business Summary

BioCardia, Inc. is a clinical-stage company developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its CardiAMP autologous mononuclear cell therapy platform targets ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina from chronic myocardial ischemia. Its allogeneic mesenchymal stem cell (MSC) platform targets ischemic inflammatory HFrEF and ARDS. Products are enabled by the Helix transendocardial biotherapeutic delivery system for minimally invasive catheter-based intramyocardial delivery.

Next Earnings

Q2 FY2026 — expected 2026-09-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBCDAdiscussed_in_filing Artificial Intelligence
topic_mentionBCDAdiscussed_in_filing Cybersecurity
topic_mentionBCDAdiscussed_in_filing Trusted Computing
topic_mentionBCDAdiscussed_in_filing Blockchain & Crypto
topic_mentionBCDAdiscussed_in_filing Regulation
topic_mentionBCDAdiscussed_in_filing Healthcare & Bio
topic_mentionBCDAdiscussed_in_filing Platform & Ecosystem
topic_mentionBCDAdiscussed_in_filing Sovereign & Government
topic_mentionBCDAdiscussed_in_filing Artificial Intelligence
topic_mentionBCDAdiscussed_in_filing Cybersecurity
topic_mentionBCDAdiscussed_in_filing Trusted Computing
topic_mentionBCDAdiscussed_in_filing Blockchain & Crypto
topic_mentionBCDAdiscussed_in_filing Regulation
topic_mentionBCDAdiscussed_in_filing Healthcare & Bio
topic_mentionBCDAdiscussed_in_filing Platform & Ecosystem
topic_mentionBCDAdiscussed_in_filing Sovereign & Government
topic_mentionBCDAdiscussed_in_filing Artificial Intelligence
topic_mentionBCDAdiscussed_in_filing Cybersecurity
topic_mentionBCDAdiscussed_in_filing Trusted Computing
topic_mentionBCDAdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-242025-12-310001437749-26-009587EDGAR83K words
2025-03-262024-12-310001437749-25-009397EDGAR—
2024-03-272023-12-310001437749-24-009587EDGAR—
2023-03-292022-12-310001437749-23-008312EDGAR—
2022-03-292021-12-310001437749-22-007544EDGAR—
2021-03-302020-12-310001437749-21-007543EDGAR—
2020-04-092019-12-310001437749-20-007405EDGAR—
2019-04-022018-12-310001437749-19-006300EDGAR—
2018-03-162017-12-310001437749-18-004870EDGAR—
2017-03-302016-12-310001437749-17-005643EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001437749-25-034437EDGAR16K words
2025-08-112025-06-300001437749-25-025826EDGAR—
2025-05-142025-03-310001437749-25-016831EDGAR—
2024-11-132024-09-300001437749-24-034896EDGAR—
2024-08-132024-06-300001437749-24-026310EDGAR—
2024-05-142024-03-310001437749-24-016611EDGAR—
2023-11-082023-09-300001437749-23-030938EDGAR—
2023-08-092023-06-300001437749-23-022780EDGAR—
2023-05-102023-03-310001437749-23-013580EDGAR—
2022-11-092022-09-300001437749-22-026591EDGAR—
2022-08-102022-06-300001437749-22-019788EDGAR—
2022-05-112022-03-310001437749-22-011905EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001437749-26-010967EDGAR1K words
2026-03-240001437749-26-009609EDGAR—
2026-03-170001437749-26-008499EDGAR—
2026-03-030001437749-26-006481EDGAR—
2026-02-100001437749-26-003582EDGAR—
2026-02-030001437749-26-002723EDGAR—
2025-12-160001437749-25-037910EDGAR—
2025-12-030001437749-25-036711EDGAR—
2025-11-240001437749-25-036076EDGAR—
2025-11-120001437749-25-034442EDGAR—

360 total filings indexed. 328 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Tags

ischemic-heart-failure-with-reduced-ejection-fraction-(hfref) chronic-myocardial-ischemia-with-refractory-angina acute-respiratory-distress-syndrome-(ards) cardiovascular-therapeutics pulmonary-diseases

Company Identity

CIK0000925741
TickerBCDA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ba913a889eca7f67ff8a2bbb7b885cae0c2f87cba114df5d8147bc272d4e2827
parent: 9e263b7f3140f9aa3c7a3c35068bf0da4b98e0520b0f6dbcc48eb13a73067464
content hash: f8bf316db0b30cbf3f591cb733a49eb4483d22b6d78988e5edbab40beb03fc6b
signed: 2026-04-13T04:43:53.929Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf